Myelodysplastic and Myeloproliferative Disorders
Myelodysplastic and Myeloproliferative Disorders are a collection of illnesses of the blood and bone marrow wherein the bone marrow makes too many white blood cells. These illnesses have functions of each myelodysplastic syndromes and myeloproliferative disorders. In myelodysplastic illnesses, the blood stem cells do now no longer mature into wholesome purple blood cells, white blood cells, or platelets and as a result, there are fewer of those wholesome cells. In myeloproliferative illnesses, a more than ordinary wide variety of blood stem cells grow to be one or a greater form of blood cells and the entire wide variety of blood cells slowly increases.
The three primary forms of myelodysplastic/myeloproliferative illnesses consist of persistent myelomonocytic leukemia (CMML); juvenile myelomonocytic leukemia (JMML); and ordinary persistent myelogenous leukemia (aCML). When a myelodysplastic/myeloproliferative disorder does now no longer in shape any of those types, it's miles known as myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-UC). Symptoms of CMML and JMML might also additionally consist of fever, feeling worn-out and weight loss. Symptoms of a CML might also additionally consist of clean bruising or bleeding and feeling worn-out or weak. Myelodysplastic/myeloproliferative illnesses might also additionally development to acute leukemia.
- Chronic myelomonocytic leukemia
- Atypical chronic myelogenous leukemia
- Symptoms
- Diagnosis
- Treatments
- Targeted therapy
- Supportive therapy
- Stem cell transplant
Related Conference of Myelodysplastic and Myeloproliferative Disorders
Myelodysplastic and Myeloproliferative Disorders Conference Speakers
Recommended Sessions
- Acute and Chronic Lymphocytic Leukemia
- Bone Marrow Transplantation
- Development of Hematopoietic Progenitor and Stem Cells
- Digital imaging in Hematology
- Disorders of Vascular Bleeding
- Epigenetic Mechanisms: Emerging Therapeutic Targets for Blood Disorders
- Genetics, Genomics, and Epigenetics
- Genome Editing and Cellular Therapy
- Hematologic Malignancy
- Hematology and Covid-19
- Hematology-Oncology
- Hemoglobin and Iron Metabolism
- Hemoglobinopathies
- Hemophilia
- Hemostasis and Thrombosis
- Immunology and Immunotherapies
- Multiple Myeloma and Other Plasma Cell Disorders
- Myelodysplastic and Myeloproliferative Disorders
- Pediatric Hematology
- Pharmacology of Chemotherapy
- Radiation Oncology or Cancer Therapy
- Transfusion Medicine
- Types of Blood Disorders
Related Journals
Are you interested in
- Advances in Hematologic Malignancies - Blood Disorders 2025 (Italy)
- Advances in Hemostasis and Thrombosis - Blood Disorders 2025 (Italy)
- Blood Disorders and the Immune System - Blood Disorders 2025 (Italy)
- Blood Disorders Diagnosis & Treatment - HEMATOLOGY 2025 (Spain)
- Blood Disorders in Aging Populations - Blood Disorders 2025 (Italy)
- Blood Transfusion - HEMATOLOGY 2025 (Spain)
- Case reports of Hematology - HEMATOLOGY 2025 (Spain)
- CellTherapy - HEMATOLOGY 2025 (Spain)
- COVID-19 and Hematology - HEMATOLOGY 2025 (Spain)
- Cutting-Edge Research in Blood Disorders - Blood Disorders 2025 (Italy)
- Disorders of Vascular Bleeding - HEMATOLOGY 2025 (Spain)
- Future Trends in Hematology: Artificial Intelligence and Big Data - Blood Disorders 2025 (Italy)
- Gene Therapy and Genetic Engineering in Hematology - Blood Disorders 2025 (Italy)
- Hematologic Toxicities and Side Effects of Cancer Therapy - Blood Disorders 2025 (Italy)
- Hematology - HEMATOLOGY 2025 (Spain)
- Hematology in Global Health: Addressing Disparities - Blood Disorders 2025 (Italy)
- Hematology Oncology - HEMATOLOGY 2025 (Spain)
- Immunohematology - HEMATOLOGY 2025 (Spain)
- Immunotherapy and Cellular Therapies in Hematology - Blood Disorders 2025 (Italy)
- Innovations in Red Blood Cell Disorders - Blood Disorders 2025 (Italy)
- Leukaemia and Lymphoma - HEMATOLOGY 2025 (Spain)
- Multiple Myeloma, Amyloidosis, and Stem Cell Transplantation - HEMATOLOGY 2025 (Spain)
- New Drug Development in Hematology - HEMATOLOGY 2025 (Spain)
- Novel Diagnostic Techniques and Biomarkers in Hematology - Blood Disorders 2025 (Italy)
- Patient Blood Management - HEMATOLOGY 2025 (Spain)
- Pediatric Hematology - HEMATOLOGY 2025 (Spain)
- Pediatric Hematology: Challenges and Innovations - Blood Disorders 2025 (Italy)
- Stem Cell Research - HEMATOLOGY 2025 (Spain)
- Stem Cell Transplantation and Regenerative Medicine - Blood Disorders 2025 (Italy)
- Thalassemia - HEMATOLOGY 2025 (Spain)
- Therapeutic Apheresis - HEMATOLOGY 2025 (Spain)
- Thrombosis and Coagulation - HEMATOLOGY 2025 (Spain)
- Transfusion Medicine - HEMATOLOGY 2025 (Spain)
- Transfusion Medicine: Advances and Challenge - Blood Disorders 2025 (Italy)
- Transfusion Transmissible Infections - HEMATOLOGY 2025 (Spain)